|
A recent study published in the Journal of the American Medical Association (JAMA)
suggests that some patients with migraine with and without aura are at increased
risk for subclinical lesions in certain brain areas. Brain lesions have been shown
to increase risk of stroke, physical limitations and cognitive impairment, including
dementia. The results of the study suggest that patients with migraine with aura
and a high attack frequency (one or more per month) are at increased risk of lesions.
Additionally, women, but not men, with migraine with and without aura are also at
increased risk. In both groups the risk increases with increasing attack frequency.
Click to read through
JAMA article
A seperate study published in the British Medical Journal (BMJ) demonstrated that
migraine may be an independent risk factor for stroke. The magnitude of this risk
remained the same for those suffering from migraine with aura and migraine without
aura. Women who were users of oral contraceptives have shown that those with a history
of migraine have twice the likelihood of developing an ischaemic stroke compared
with those without migraine.
Click to read BMJ
article
Medication Overuse Headache (MOH) is a frequent headache caused by overuse of medication,
particularly those that treat migraine. Although evidence suggests that frequent
use of analgesics may not cause MOH in everyone, overuse of medications by migraine
sufferers is often found to increase the frequency of attacks. Studies have shown
that a number of medications may cause MOH and that only by discontinuing use of
such medications can the symptoms of MOH be avoided. These medications include:
- Triptans
- Ergotamines
- Common analgesics such as acetaminophen.
- Opioids
- Combination medications such as
- Butalbital compounds containing aspirin or acetaminophen, butalbital and caffeine.
- Vicodin
- Other compounds containing more than one medication.
MigraSpray and the ingredients within its proprietary formulation have not been
shown to cause MOH and can be used as frequently as necessary to effectively prevent
and treat migraine. It is not known whether MigraSpray is effective for treating
the acute symptoms of MOH. A patient suffering from MOH that continues taking medications
that may cause or contribute to MOH may not receive maximum benefit from MigraSpray.
In order to obtain the best results it is recommended that the migraine sufferer
begin using MigraSpray and gradually decrease their dosages of medications that
may contribute to MOH until use of those medications has been discontinued.
MigraSpray was shown to be highly effective in preventing migraine in a study of
patients suffering from frequent migraines conducted by Dr. Fred Pescatore, Director
of the Centers for Integrative and Complimentary Medicine in New York City and Dallas.
The participants in the study used MigraSpray each day and approximately 90% had
their migraine attacks eliminated as long as they continued with regular daily usage.
|